Menu
Back to User profile » Dr George Ousler
Papers published by Dr George Ousler:
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
Taylor M, Ousler G, Torkildsen G, Walshe C, Fyfe MCT, Rowley A, Webber S, Sheppard JD, Duggal A
Clinical Ophthalmology 2019, 13:261-275
Published Date: 12 February 2019
The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
Stonecipher KG, Torkildsen GL, Ousler III GW, Morris S, Villanueva L, Hollander DA
Clinical Ophthalmology 2016, 10:887-895
Published Date: 13 May 2016
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
Sosne G, Ousler GW
Clinical Ophthalmology 2015, 9:877-884
Published Date: 20 May 2015
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
Ousler III G, Devries DK, Karpecki PM, Ciolino JB
Clinical Ophthalmology 2015, 9:235-243
Published Date: 5 February 2015
Blink patterns and lid-contact times in dry-eye and normal subjects
Ousler GW 3rd, Abelson MB, Johnston PR, Rodriguez J, Lane K, Smith LM
Clinical Ophthalmology 2014, 8:869-874
Published Date: 5 May 2014
Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye
Meerovitch K, Torkildsen G, Lonsdale J, Goldfarb H, Lama T, Cumberlidge G, Ousler GW III
Clinical Ophthalmology 2013, 7:1275-1285
Published Date: 26 June 2013
Automated grading system for evaluation of ocular redness associated with dry eye
Rodriguez JD, Johnston PR, Ousler III GW, Smith LM, Abelson MB
Clinical Ophthalmology 2013, 7:1197-1204
Published Date: 20 June 2013
Investigation of extended blinks and interblink intervals in subjects with and without dry eye
Rodriguez JD, Ousler III GW, Johnston PR, Lane K, Abelson MB
Clinical Ophthalmology 2013, 7:337-342
Published Date: 14 February 2013
The interblink interval in normal and dry eye subjects
Johnston PR, Rodriguez J, Lane KJ, Ousler G, Abelson MB
Clinical Ophthalmology 2013, 7:253-259
Published Date: 1 February 2013
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
Gomes PJ, Ousler GW, Welch DL, Smith LM, Coderre J, Abelson MB
Clinical Ophthalmology 2013, 7:157-165
Published Date: 20 January 2013
A single-center study evaluating the effect of the controlled adverse environment (CAEsm) model on tear film stability
Abelson R, Lane KJ, Rodriguez J, Johnston P, Angjeli E, Ousler G, Montgomery D
Clinical Ophthalmology 2012, 6:1865-1872
Published Date: 13 November 2012
Measurement of ocular surface protection under natural blink conditions
Abelson R, Lane KJ, Angjeli E, Johnston P, Ousler G, Montgomery D
Clinical Ophthalmology 2011, 5:1349-1357
Published Date: 22 September 2011
Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial
Patane MA, Cohen A, From S, Torkildsen G, Welch D, Ousler GW 3rd
Clinical Ophthalmology 2011, 5:633-643
Published Date: 15 May 2011